Clinical Trial Update: Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting efficacy and safety data for SP-8203 in patients with ischemic stroke requiring rtPA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• SP-8203

Snippet

Sponsor: Shin Poong Pharmaceutical Co. Ltd. | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED